Chih‐Hsi S. Kuo - Concepedia

Author

Chih‐Hsi S. Kuo

Also Known As

CHIH-HSI SCOTT KUO, Cheng‐Ta Yang, Chih-Hsi Kuo, Chih-Hsi S. Kuo, Chih-Hsi Scott Kuo, Chihhsi Kuo, Chih‐Hsi S. Kuo, Chih‐Hsi Scott Kuo, Ching‐Fu Chang, Kuo, Chih-Hsi Scott

175

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Chang Gung University Linkou Chang Gung Memorial Hospital Chang Gung Memorial Hospital Imperial College London Kaohsiung Chang Gung Memorial Hospital

About

Chih‐Hsi S. Kuo is an author at Chang Gung University specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	400
2	Immunology	3	3	309
3	Allergy	2	2	232
4	Health Sciences	1	1	11
5	Molecular Medicine	1	1	11

Chih‐Hsi S. Kuo

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED Chih‐Hsi S. Kuo, Stelios Pavlidis, Matthew J. Loza, European Respiratory Journal	2017	348
Trastuzumab Deruxtecan in Patients With <i>HER2</i>-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial Kōichi Goto, Yasushi Goto, Toshio Kubo, Journal of Clinical Oncology	2023	250
Sputum transcriptomics reveal upregulation of IL-1 receptor family members in patients with severe asthma Christos Rossios, Stelios Pavlidis, Uruj Hoda, Journal of Allergy and Clinical Immunology InflammationAsthmaCytokineAllergyInflammatory Lung Disease	2017	201
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED Chih‐Hsi S. Kuo, Stelios Pavlidis, Matthew J. Loza, American Journal of Respiratory and Critical Care Medicine	2016	199
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial D. Ross Camidge, Jair Bar, Hidehito Horinouchi, Journal of Clinical Oncology	2024	99
Bevacizumab Reduces S100A9-Positive MDSCs Linked to Intracranial Control in Patients with EGFR-Mutant Lung Adenocarcinoma Po‐Hao Feng, Kuan-Yuan Chen, Yu‐Chen Huang, Journal of Thoracic Oncology MedicineImmunologyEgfr-mutant Lung AdenocarcinomaPathologyImmune Checkpoint Inhibitor	2018	77
Metabolic re-patterning in COPD airway smooth muscle cells Charalambos Michaeloudes, Chih‐Hsi S. Kuo, Gulam Haji, European Respiratory Journal	2017	69
Accidental swallowing of an endodontic file Chih‐Hsi S. Kuo, Yi‐Lung Chen International Endodontic Journal	2008	68
Contribution of airway eosinophils in airway wall remodeling in asthma: Role of <i><scp>MMP</scp>‐10</i> and <i><scp>MET</scp></i> Chih‐Hsi S. Kuo, Stelios Pavlidis, Jie Zhu, Allergy	2019	44
Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of <i>EGFR</i> -Mutant and <i>RET</i> Fusion-Positive Lung Cancers Julia Rotow, Jyoti D. Patel, Matthew P. Hanley, Clinical Cancer Research	2023	40

Page 1